STAG INDUSTRIAL ANNOUNCES TAX TREATMENT OF 2024 DIVIDENDS

STAG Industrial, Inc.(the “Company”) (NYSE: STAG) today announced the tax treatment of its 2024 dividends to holders of its common stock. https://mma.prnewswire.com/media/95729/stag_industrial__inc__logo.jpg The tax treatment for the common stock dividend is detailed in the investor relations section on the Company's website and is summarized below. Shareholders are encouraged to consult with their personal tax advisors […]

Enterprise Bancorp, Inc. Announces Quarterly Dividend

(NASDAQ:EBTC), LOWELL, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) — Enterprise Bancorp, Inc. (the “Company”) (NASDAQ:EBTC) On January 21, 2025, the Board of Directors of Enterprise Bancorp, Inc. declared a quarterly dividend of $0.25 per share to be paid on March 3, 2025, to shareholders of record as of February 10, 2025. Enterprise Bancorp, Inc. is

Zillow Group to Announce Fourth-Quarter and Full-Year 2024 Results Feb. 11

Conference call to be webcast live at 2 p.m. PT / 5 p.m. ET Zillow Group, Inc. (Nasdaq: Z and ZG) today announced it will release fourth-quarter and full-year 2024 financial results after market close on Tuesday, Feb. 11, 2025. The company will host a webcast and conference call to discuss its results that afternoon

Harmonic Announces Reporting Date for Fourth Quarter and Full Year 2024 Results

Harmonic (NASDAQ: HLIT) today announced it will release its fourth quarter and full year 2024 financial results after the market close on Monday, February 10, 2025. Harmonic will host a live webcast to discuss the Company's results at 2:00 p.m. PT on the same day. https://mma.prnewswire.com/media/455698/HARMONIC_Inc_logo.jpg To participate via telephone, please register in advance using

The Inner Circle acknowledges, Thomas Su, MD as a Pinnacle Lifetime Member

Prominently featured in The Inner Circle, Thomas Su, MD is acknowledged as a Pinnacle Lifetime Member for his contributions to Cosmetic and Aesthetic Liposuction. Dr. Thomas Su is a dedicated medical professional specializing in liposuction procedures for cosmetic enhancement and for patients suffering from lipedema. His unique blend of artistic talent and medical expertise drives

The Inner Circle acknowledges, David M. Williams, MD as a Pinnacle Life Member

Prominently featured in The Inner Circle, David M. Williams, MD, is acknowledged as a Pinnacle Life Member for his contributions to the field of Epidemiology. Dr. Williams pursued higher education at the Universidad Autónoma de Guadalajara in Mexico where he earned a Bachelor of Science in Biology. He then attended Emory University's Morehouse School of

The Inner Circle acknowledges, Debra Salter, MD, ABOM as a Pinnacle Lifetime Member

Prominently featured in The Inner Circle, Debra Salter, MD, ABOM is acknowledged as a Pinnacle Lifetime Member for her contributions to Obesity Medicine and Holistic Patient Care. Dr. Debra Salter is a recognized authority in obesity medicine, dedicated to helping patients achieve sustainable weight loss and overall wellness. Operating her private practice locally, Dr. Salter

The Inner Circle acknowledges, James E. Davison, DC as a Pinnacle Lifetime Member

Prominently featured in The Inner Circle, James E. Davison, DC is acknowledged as a Pinnacle Lifetime Member for his contributions to Chiropractic Care and Community Outreach. Dr. James E. Davison, DC, is a dedicated chiropractor renowned for his gentle adjustments and comprehensive care approach, specializing in treating patients who have sustained injuries from auto accidents

Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer

Dr. Gehchan brings decades of successful late-stage clinical development and commercial experience to role, further enhancing Kyverna's senior leadership team to execute Company's next wave of growth Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced the appointment of Naji Gehchan, M.D.,

Neurocrine Biosciences Announces Classic Congenital Adrenal Hyperplasia Supplement Published Today in The Journal of Clinical Endocrinology & Metabolism

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced publication of a classic congenital adrenal hyperplasia (CAH)-focused supplement in The Journal of Clinical Endocrinology & Metabolism (JCEM), sponsored by the company. The supplement, titled “Challenges and Opportunities in the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency Throughout the Lifetime,” contains eight review articles that

Scroll to Top